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Effects of the carcinogen methylazoxymethaaol acetate on protein syathesis aad drag metabolism 
ia rat livers* 
(Received 2 November 1970; accepted 12 February 1971) 
METHYLAZOXYMETHANOL (MAM) acetate is a synthetic derivative of cycasin, a carcinogen derived 
from plants of the cycad fami1y.‘*2 Cycasin, MAM and MAM acetate have been shown to induce 
tumors primarily in the liver, kidney, and intestine of rats after a single or small number of doses.3-5 
Zedeck et al? reported that there was a rapid inhibition of DNA, RNA and protein synthesis which 
occurred in liver within 3 hr after giving MAM acetate. In addition, nucleolar damage was evident 
within 1 hr and preceded inhibition of nuclear RNA synthesis. Disaggregation of polysomes and 
depletion of rough endoplasmic reticulum have also been observed to occur in rat liver within a few 
hours after giving MAM.6*7 The present study was undertaken to determine the effects of MAM 
acetate on various functions of the microsomal fraction of rat liver in order to further elucidate bio- 
chemical actions of the carcinogen which might be involved in the initial events leading to formation 
of neoplasia. The effects of MAM acetate were compared to those of dimethylnitrosamine @MN), 
a chemically similar carcinogen. The agents were found to have very similar effects on protein syn- 
thesis and drug-metabolizing enzymes. 
MAM acetate was purchased from Mann Research Laboratories, Inc., dimethylnitrosamine from 
Eastman Kodak Co., and L-leucine-4,VH (38.5 c/m-mole) from New England Nuclear Corp. Male 
Sprague-Dawley rats (60-70 g) were obtained from Spartan Farms, Lansing, Mich. and allowed 
food and water ad lib. 
All injection solutions were prepared in 0.9% NaCl. Injections were given intraperitoneally in a 
volume of 0.2 ml with the exception of pulsedoses of L-leucine-3H, which were given by tail vein 
injection. Control animals were injected with saline solution. All animals were sac&iced by decapita- 
tion. For the drug metabolism studies, the animals were sacrificed between 8 and 9 a.m. In the case 
of polysome preparations, all animals were sacrificed between 1 and 2 p.m. to avoid possible diurnal 
variations in polysome pattems.8 
* Address reprint requests to: Dr. R. W. Ruddon, Pharmacology Section, Department of Oral 
Biology, University of Michigan Dental School, AM Arbor, Michigan 48104, U.S.A. 
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To prepare microsomes animals were decapitated, and their livers immediately removed, rinsed 
in iced 025 M sucrose-3 mM MgClz, placed in 3 vol. of sucrose-MgClz solution in a Dounce tube, 
and homogenized. The homogenate was centrifuged at 12,500g at 0” for 24Jmin. The postmitochondrlal 
supematant was then centrifuged at 105,000 g for 60 min at 0” in a Spinco 50 Ti rotor. The micro- 
somal pellets were washed by resuspension in sucrose-MgCl, solution and recentrifugationat 105,800 
g for 60 min. Metabolism of ethylmorphine and norcodeine was determined in microsomes by a 
modification of the method of George and Tephly.g Reaction mixtures (5 ml) contained 0.5 m-mole 
of phosphate buffer (PH 7.4), 0.3 m-mole of KCl, 2.25 pmoles of MgCII, 38 pmoles of semicarbazide- 
HCl, 6 pmoles of glucose dphosphate, 2.2 pmoles NADP, 4 pmoles of ethylmorphine or norco- 
deine, 2 units of glucose 6-phosphate dehydrogenase, and S-10 mg of microsomal protein. The samples 
were incubated for 10 min at 37”, and the reactions stopped by the addition of @4 ml of 70% perch- 
loric acid. Metabolism was estimated by the production of formaldehyde according to the procedure 
of Nash.‘O Protein determinations were done by the method of Lowry et al.” 
Polyribosomes were prepared by the procedure of Blobel and Potteri and analyzed on 10-30 per 
cent linear sucrose gradients. The area of monomer and dimer peaks and the total area of the poly- 
some patterns were measured by a compensating polar planimeter. The percentage of intact polysomes 
was calculated as the per cent of the total area composed of the monomer plus dimer peaks sub- 
tracted from 100 per cent. 
Incorporation of 3H-leucine (50 c(c) into microsomal protein was determined after a 10 min pulse- 
dose given intravenously. Aliquots (1 ml) of microsomal suspension containing approximately 2 mg 
of microsomal protein were added to 10 ml of Scintisol-toluene counting solution (2 ml of Scintisol 
per 10 ml of toluene scintillator solution [3 g PPO, 100 mg POPOP/l. toluene]) and counted on 
a Packard Tri-carb liquid scintillation spectrometer. 
Incorporation of 3H-leucine into microsomal protein in uiuo was measured at various times after 
a 20 mg/kg dose of MAM acetate (Fig. 1). Protein synthesis was inhibited 50 per cent below control 
levels 1 hr after treatment, and maximal inhibition (70 per cent) was observed at 2 hr. Incorporation 
of labeled amino acid returned to control levels by 24 hr after a single injection. The inhibition of 
polypeptide formation cannot be explained on the basis of an inhibitory effect of MAM acetate on 
the equilibration of labeled leucine with the amino acid pool in liver. The specific activitiesof the acid 
soluble pools from liver homogenates in two separate experiments were 1572 and 2293 counts/min/ 
Azao for the controls, while the corresponding values for animals treated with 20 mg/kg of MAM 
acetate were 1789 and 3204 counts/min/A 2so respectively, This pattern of inhibition of protein 
synthesis was similar to that reported by Zedeck et ok5 with the exception that we observed a peak 
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FIG. 1. Effect of MAM acetate (20 mg/kg) on hepatic protein synthesis and polysome aggregation. 
Incorporation of leucine-4,5-3H into microsomal protein and polysome aggregation were determined 
as described in the text. For each time period studied the livers of two rats were pooled for both 
control and MAM acetate-treated animals. The range in incorporation of labeled leucine into micro- 
somal protein (striped bar) was based on data from 12 control animals. The range of “intact poly- 
somes” (minus monomer and dimer area) was based on determinations from eight animals (solid bar). 
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studies reported herein a relationship was established between decreased polypeptide formation and 
polysome disaggregation (Fig. 1). The polysome patterns 2 and 24 hr after MAM acetate are shown 
in Figs. 2 and 3. 
CONTROL - 
BOTTOM -TOP 
FIG. 2. Polysome patterns at 2 hr after MAM acetate (20 mg/kg). 
BOTTOM -TOP 
FIG. 3. Polysome patterns at 24 hr after MAM acetate (20 m&kg). 
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The effects of DMN on hepatic protein synthesis in viva and polysome aggregation were very similar 
to those of MAM acetate.* These latter findings are in agreement with those of Villa-Trevino.i3 
Inhibition of incorporation of nucleotide precursors into nuclear RNA does not precede protein 
synthesis inhibition after giving MAM or DMN, suggesting that decreased protein synthesis is not due 
to lower levels of RNA?*r3 
In order to measure an additional parameter of microsomal function, the effects of MAM acetate 
on drug-metabolizing enzymes and the ability of phenobarbital to induce these enzyme systems were 
examined. Ethyhnorphine N-demethylase activity in microsomes was inhibited in a dose-dependent 
manner by the carcinogen (Fig. 4). However, the 0-dealkylation of norcodeine was not markedly 
decreased until a dose of 20 mg/kg or larger was given. This differential inhibition of microsomal 
oxidases suggests that different rate-limiting events might be involved in these two systems or that 
the half-life of key components of the enzyme system might be longer in the case of norcodeine O- 
dealkylation. Alteration of other environmental conditions has been shown to affect these oxidase 
systems differently.9 In the experiments represented in Table 1, ethylmorphine metabolism was 
inhibited 24 hr after a 20 mg/kg dose of MAM acetate. By 72 hr after carcinogen, ethylmorphine 
metabolism was still below control levels; however, the ability of the system to be induced by pheno- 
barbital was not impaired at 24 hr after MAM treatment since giving phenobarbital at this time 
produced the same incremental increase above noninduced levels as in the phenobarbital-treated 
controls. Enzyme activity in the animals that received both MAM acetate and phenobarbital did 
not reach the same absolute level as in the animals treated with phenobarbital and saline. The data 
presented in Table 2 indicates that the effects of DMN on microsomal oxidases were very similar 
to those of MAM acetate; there was a dose-dependent inhibition of ethylmorphine metabolism and a 






NC EM NC EM NCEM 
5 IO IS 
EM NC 
'0 
DOSE Of MAM acetate (mq/kqJ 
FIO. 4. Effects of various doses of MAM acetate on ethylmorphine (EM) and norcodeine (NC) 
metabolism in hepatic microsomes. Enzyme assays performed as described in the text. Each determina- 
tion was based on duplicate samples from the pooled livers of two control or two treated animals, 
except for the 30 mg/kg dose which represents the mean f S.E. for six animals in each group. The 
specitic activities (in mpmoles formaldehyde formed per milligram protein per minute) of the micro- 
somal preparations from control animals (averaged from all experiments) were 4.26 f 0.54 (S.E.) 
for EM and 2.63 f 0.31 for NC. Animals were sacrificed 24 hi after injection of MAM acetate 
or saline. 
* G. S. Banks, P. B. Lundeen and R. W. Ruddon, unpublished observations. 
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TABLE 1. INDUCIXON OF ~~HYLMORP~NE iV-DEMETHYLASE ACTIVITY IN ANIMALS TREATED wrITi MAM 
ACETATE* 
Time after MAM Phenobarbital 
[Experiment treatment (hr) Control MAM acetate Phenobarbital and MAM acetate 
1 24 264 1.66 c-37 %) 
48 3.23 2.63 (-19%) 6.23 (+93%) 5.43 (+106%) 
72 3.55 2.31 (-35%) 7.10 (+lOO%) 5.03 (+llso%) 
2 24 2.97 1.10 (-63 %) 
48 4.67 1.50 (-68%) 10*67(+128%) 3.56 (+137’%) 
* Animals were given MAM acetate (20 mg/kg in Experiment 1 and 30 mg/kg in Experiment 2) at 
0 time, then phenobarbital (40 mg/kg) at 24 or 48 hr after MAM acetate, and sacrificed 24 hr after 
phenobarbital was given. Controls were injected with @9% NaCl at 0,24 and 48 hr. Ethyhnorphine 
metabolism is expressed as mpmoles formaldehyde formed per milligram microsomal protein per 
minute. Values represent the mean of duplicate determinations from the pooled livers of two animals. 
Numbers in parentheses represent per cent change from control or in the case of the phenobarbital- 
treated animals, per cent change from the “noninduced” level. 
TABLE 2. DRUG-METABOLIZING ENZYME ACTIVITY 24 hr AFI’ER TREATMENT 
WITH DI* 
Experiment Enzyme assay Control Dose of DMN (mg/kg) 






2.42 (-60%) (-182$ 
1.78 
(--26’%) (-43%) 
3.16 7.5 15 20 
2.37 2.12 090 
(-25%) (-330%) (-72%) 
* Enzyme activity determined and expressed as stated in Table 1. 
The evidence accumulated on inhibition of drug-metabolizing enzymes agrees with the pattern of gen- 
eral inhibition of protein synthesis. Twenty-four hr after treatment with 20 mg/kg of MAM acetate, 
drug-metabolizing enzymes were inhibited approximately 50 per cent. This inhibition could be due to 
the disruption of normal enzyme synthesis during the 24-hr period. Although only slight recovery 
of normal enzyme activity appears to occur in the 72 hr following MAM acetate, the capacity to 
increase enzyme levels recovers by 24 hr as evidenced by the ability of phenobarbital to induce 
microsomal enzyme activity. This suggests that the mechanism for enzyme synthesis is intact by that 
time. 
It has been postulated that MAM and DMN have a common methylating intermediate formed in 
vivo.‘4*‘5 The methylation of mRNA could lead to polysome disaggregation and accelerated break- 
down of mRNA, possibly accounting for the common pattern of protein synthesis inhibition. The 
similarities in the effects of DMN and MAM acetate on protein synthesis, polysome breakdown, 
and drug-metabolizing enzymes suggest a common mechanism of action of these agents. Whether 
or not these alterations are related to their carcinogenic potential remains to be determined. 
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‘Tittration” of acetylehoiinesterase with soman 
(Received 28 December 1970; accepted 25 March 1971) 
PREVIOUSLY described methods1 for estimation of the number of active sites in acetylcholinesterase- 
preparations (AChE, EC 3.1.1.7) seem to he rather troublesome and often expensive with respect 
to working time and the required amount of test material. The applicability of a more recently 
reported analytical procedure, described by Bender ef aL2 is confined to preparations of relative high 
enzymatic activity. We should like to report on a considerably less expensive method in which only 
about 10T6 moles of acetylcholme are split per min per mg of enzyme; the active site concentration 
is in the range of IO-l2 moles/mg enzyme, which is far below the required concentration for any 
direct (e.g. optical) detection method.* 
The simple analytical procedure used in our laboratory is based on the measurement of the enzymic 
activity of AChE after partial inhibition by the phosphonylating agent soman [0-(I-methyl-2.2- 
dimethylpropyl)-methyl-fluorophosphonate]. 
Due to the presence of two asymmetric centers (the P-atom and the C-l-atom of the l-methyl-2.2- 
dimethylpropyl-residue), soman consists of four stereoisomers. Keijer and Wolring4 found in 1969 
that two of them (with the same configuration around the P-atom) react very fast with AChE (inhi- 
bition rate constants k, = 2.8 x 10’ and 1.2 x lo8 M-l min-’ respectively), whereas the other two 
are relatively poor inhibitors (k, d lo4 M-’ min-I). Concerning the stereospecificity of chymo- 
trypsin towards soman, Ooms and van Dijk5 reported a very similar observation: one pair of diastere- 
omers (with identical configurations at the P-atoms) reacts fast (k, = 2.0 x 10’ for both), the other 
slowly (k, c 103). The method reported here is based on these findings. 
(a) Determination of concentrarion of the soman stock solution 
The solvent used for all stock solutions and experiments was distilled water containing O-1 M NaCl 
and 0.02 M MgC12. In order to determine accurately the concentration of fast-reacting soman in 
stock solutions, the inhibition of chymotrypsin was measured. 
* When this work was in progress, M. Nenner reported another method for the determination of 
active sites, based upon a special kinetical treatment of the bimolecular reaction between AChE 
and an organophosphorous inhibitor.3 
